A
AUTOLUS THERAPEUTICS LTD
NASDAQ: AUTL (Autolus Therapeutics plc)
Last update: 2 hours ago1.88
-0.08 (-4.08%)
| Previous Close | 1.96 |
| Volume | 1,723,255 |
| Price / Sales | 4.26 |
| Price / Book | 6.69 |
| 52 Weeks Range |
| Operating Margin (TTM) | -726.31% |
| Diluted EPS (TTM) | -0.880 |
| Quarterly Revenue Growth (YOY) | -11.00% |
| Total Debt/Equity (MRQ) | 83.84% |
| Current Ratio (MRQ) | 9.24 |
| Operating Cash Flow (TTM) | -241.32 M |
| Levered Free Cash Flow (TTM) | -214.39 M |
| Return on Assets (TTM) | -20.27% |
| Return on Equity (TTM) | -49.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Autolus Therapeutics plc | Mixed | Bearish |
AIStockmoo Score
-2.3
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -4.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -2.25 |
|
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 18.09% |
| % Held by Institutions | 90.89% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Syncona Portfolio Ltd | 30 Jun 2026 | 16,640,720 |
| Tetragon Partners Gp Ltd | 30 Jun 2026 | 9,500,000 |
| Laurion Capital Management Lp | 30 Jun 2026 | 3,316,626 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| PICCINA CINTIA | - | 2.24 | -6,713 | -15,037 |
| Aggregate Net Quantity | -6,713 | |||
| Aggregate Net Value ($) | -15,037 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 2.24 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PICCINA CINTIA | Officer | 02 Sep 2026 | Sell (-) | 6,713 | 2.24 | 15,037 |
| PICCINA CINTIA | Officer | 01 Sep 2026 | Option execute | 20,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |